PATENT CLAIM ANALYSIS

Application Number: 16143788
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "210000"]

Abstract:
The present invention relates to novel compounds that inhibit Lp-PLA 2  activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA 2 , for example Alzheimer's disease.

Claim (Index 20):
The compound or a pharmaceutically acceptable salt thereof according to  claim 11  is Formula (A-5), wherein\n R 1  and R 2  together with the nitrogen and carbon to which they are attached form a 6-membered saturated ring, which ring contains one additional heteroatom ring member selected from the group consisting of O and which ring has no further substitution; \n R 5  and R 9  are independently H or F; \n R 6  and R 8  are independently selected from the group consisting of H or F; and \n W 1  is selected from the group consisting of pyridinyl or primidinyl, wherein said pyridinyl, pyrimidinyl, pyrazolyl or phenyl is optionally substituted with one or two substituents independently selected from the group consisting of CF 3  and CH 3 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.32353
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15327706', '14761636', '14234680', '14234687', '14569970']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8470835256686656
- 35 USC 102 Novelty (BERT): 0.5718223003632362
- Combined Prediction Score: 0.8195574031381226
- Mean Citation Score: 381.661348
- Max Citation Score: 451.69055
- Similarity Product: 446.5760960457891

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test